Localization of the mRNA Encoding Prolyl Endopeptidase in the Rat Brain and Pituitary

Journal of Comparative Neurology

Volumn 471, Issue 2, 2004, Pages 128-143

  Bellemère, Gaelle ^a   Vaudry, Hubert ^a   Mounien, Lourdes ^a   Boutelet, Isabelle ^a   Jégou, Sylvie ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Neuropeptide metabolism; PEP; Rat brain; Serine protease

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE RECEPTOR; PROLYL ENDOPEPTIDASE; SERINE PROTEINASE;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN REGION; CRANIAL NERVE; DENTATE GYRUS; ENZYME ANALYSIS; ENZYME LOCALIZATION; GIANT CELL; GRANULE CELL; HIPPOCAMPUS; HISTOCHEMISTRY; HYPOPHYSIS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MOTONEURON NUCLEUS; NONHUMAN; PRETECTUM; PRIORITY JOURNAL; PURKINJE CELL; PYRAMIDAL NERVE CELL; QUANTITATIVE ANALYSIS; RAT; RED NUCLEUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEPTUM PELLUCIDUM; SUBSTANTIA NIGRA; THALAMUS ANTERIOR NUCLEUS; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; MALE; NEUROGLIA; NEURONS; PITUITARY GLAND; RATS; RATS, WISTAR; RNA, MESSENGER; SERINE ENDOPEPTIDASES;

EID: 1542314779     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20019     Document Type: Article

References (84)

1. Alescio-Lautier B, Paban V, Soumireu-Mourat B. 2000. Neuromodulation of memory in the hippocampus by vasopressin. Eur J Pharmacol 405:63-72.
2. Bellemère G, Morain P, Vaudry H, Jégou S. 2003. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and α-melanocyte-stimulating hormone breakdown in the rat brain. J Neurochem 84:919-929.
3. Berridge MJ, Downes CP, Hanley MR. 1989. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59:411-419.
4. Bourguignon JP, Alvarez Gonzalez ML, Gerard A, Franchimont P. 1994. Gonadotropin releasing hormone inhibitory autofeedback by subproducts antagonist at N-methyl-D-aspartate receptors: a model of autocrine regulation of peptide secretion. Endocrinology 134:1589-1592.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Csuhai E, Little SS, Hersh LB. 1995. Inactivation of neuropeptides. Prog Brain Res 104:131-142.
7. Daly DJ, Maskrey P, Pennington RJT. 1985. Characterization of proline endopeptidase from skeletal muscle. Int J Biochem 17:521-524.
8. Dauch P, Masuo Y, Vincent JP, Checler F. 1993. A survey of the cerebral regionalization and ontogeny of eight exo- and endopeptidases in murines. Peptides 14:593-599.
9. Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M, McCracken J. 2001. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24:359-369.
10. 4-9 in the radial maze. Behav Brain Res 87:201-208.
11. Dietrich A, Taylor JT, Passmore CE. 2001. AVP (4-8) improves concept learning in PFC-damaged but not hippocampal-damaged rats. Brain Res 919:41-47.
12. 3) in the central nervous system of the rat. J Comp Neurol 364:290-310.
13. Dresdner K, Barker LA, Orlowski M, Wilk S. 1982. Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain. J Neurochem 38:1151-1154.
14. Facchinetti P, Rose C, Rostaing P, Triller A, Schwartz JC. 1998. Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain. Neuroscience 88:1225-1240.
15. Facchinetti P, Rose C, Schwartz JC, Ouimet T. 2003. Ontogeny, regional and cellular distribution of the novel metalloprotease neprilysin 2 in the rat: a comparison with neprilysin and endothelin-converting enzyme-1. Neuroscience 118:627-639.
16. Fülöp V, Böcskei Z, Polgár L. 1998. Prolyl endopeptidase: an unusual β-propeller domain regulates proteolysis. Cell 94:161-170.
17. Fülöp V, Szeltner Z, Polgár L. 2000. Catalysis of serine oligopeptidases is controlled by a gating filter mechanism. EMBO Rep 1:277-281.
18. Fuse Y, Polk DH, Law RW, Reviczky AL, Fisher DA. 1990. Distribution and ontogeny of thyrotropin-releasing hormone degrading enzymes in rats. Am J Physiol 259:E787-E791.
19. Gaudoux F, Boileau G, Crine P. 1993. Localization of neprilysin (EC 3.4.24.11) mRNA in rat brain by in situ hybridization. J Neurosci Res 34:426-433.
20. Grady E, Bohm S, McConalogue K, Garland A, Ansel J, Olerud J, Bunnett N. 1997. Mechanisms attenuating cellular responses to neuropeptides: extracellular degradation of ligands and desensitization of receptors. J Investig Dermatol Symp Proc 2:69-75.
21. Healy DP, Orlowski M. 1992. Immunocytochemical localization of endopeptidase 24.15 in rat brain. Brain Res 571:121-128.
22. Heuer H, Schäfer MKH, O'Donnell D, Walker P, Bauer K. 2000. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol 428:319-336.
23. Huston JP, Oitzl MS. 1989. The relationship between reinforcement and memory: parallels in the rewarding and mnemonic effects of the neuropeptide substance P. Neurosci Biobehav Rev 13:171-180.
24. Irazusta J, Larrinaga G, González-Maeso J, Gil J, Meana JJ, Casis L. 2002. Distribution of prolyl endopeptidase activities in rat and human brain. Neurochem Int 40:337-345.
25. Ishino T, Ohtsuki S, Homma K, Natori S. 1998. cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells. J Biochem (Tokyo) 123:540-545.
26. Jessop DS, Chowdrey HS, Lightman SL. 1990. Substance P and substance K in the median eminence and paraventricular nucleus of the rat hypothalamus. Neuropeptides 17:135-140.
27. Johren O, Imboden H, Hauser W, Maye I, Sanvitto GL, Saavedra JM. 1997. Localization of angiotensin-converting enzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus. Brain Res 757:218-227.
28. Kalwant S, Porter AG. 1991. Purification and characterization of human brain prolyl endopeptidase. Biochem J 276:237-244.
29. Kato T, Okada M, Nagatsu T. 1980. Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues. Mol Cell Biochem 32:117-121.
30. Kato A, Fukunari A, Sakai Y, Nakajima T. 1997. Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse. J Pharmacol Exp Ther 283:328-335.
31. Kimura A, Takahashi T. 2000. cDNA cloning of rat prolyl oligopeptidase and its expression in the ovary during the estrous cycle. J Exp Zool 286:656-665.
32. Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, Elmquist JK. 2003. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 457:213-235.
33. Koida M, Walter R. 1976. Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J Biol Chem 251:7593-7599.
34. Kouznetsova M, Nistri A. 2000. Facilitation of cholinergic transmission by substance P methyl ester in the mouse hippocampal slice preparation. Eur J Neurosci 12:585-594.
35. Kovács GL, Veldhuis HD, Versteeg DH, De Wied D. 1986. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures. Brain Res 371:17-24.
36. Krall WJ, Sramek JJ, Cutler NR. 1999. Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Ann Pharmacother 33:441-450.
37. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortes C. 1998. Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain. Neuroscience 82:827-841.
38. Lew RA, Tetaz TJ, Glucksman MJ, Roberts JL, Smith AI. 1994. Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts. J Biol Chem 269:12626-12632.
39. Lew RA, Cowley M, Clarke IJ, Smith AI. 1997. Peptidases that degrade gonadotropin-releasing hormone: influence on LH secretion in the ewe. J Neuroendocrinol 9:707-712.
40. Lolait SJ, O'Carroll AM, Mahan LC, Felder CC, Button DC, Young WS 3rd, Mezey E, Brownstein MJ. 1995. Extrapituitary expression of the rat Vlb vasopressin receptor gene. Proc Natl Acad Sci U S A 92:6783-6787.
41. Maeno H, Kiyama H, Tohyama M. 1993. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Mol Brain Res 18:43-58.
42. Maes M, Goossens F, Scharpé S, Calabrese J, Desnyder R, Meltzer HY. 1995. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res 58:217-225.
43. Matsas R, Rattray M, Kenny AJ, Turner AJ. 1985. The metabolism of neuropeptides. Endopeptidase-24.11 in human synaptic membrane preparations hydrolyses substance P. Biochem J 228:487-492.
44. Matsumura R, Takagi C, Kakeya T, Okuda K, Takeuchi S, Takahashi S. 2003. α-Melanocyte-stimulating hormone stimulates prolactin secretion through melanocortin-3 receptors expressed in mammotropes in the mouse pituitary. Neuroendocrinology 78:96-104.
45. Merchenthaler I, Lennard DE. 1991. The hypophysiotropic neurotensin-immunoreactive neuronal system of the rat brain. Endocrinology 129:2875-2880.
46. Miura N, Shibata S, Watanabe S. 1995. Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats. Neurosci Lett 196:128-130.
47. Morain P, Robin JL, De Nanteuil G, Jochemsen R, Heidet V, Guez D. 2000. Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study. Br J Clin Pharmacol 50:350-359.
48. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. 1994. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298-1308.
49. Noble F, Banisadr G, Jardinaud F, Popovici T, Lai-Kuen R, Chen H, Bischoff L, Parsadaniantz SM, Fournie-Zaluski MC, Roques BP. 2001. First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [125I]RB 129. Neuroscience 105:479-488.
50. O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH. 2000. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Res 880:84-91.
51. O'Leary RM, Gallagher SP, O'Connor B. 1996. Purification and characterization of a novel membrane-bound form of prolyl endopeptidase from bovine brain. Int J Biochem Cell Biol 28:441-449.
52. Ostrowski NL, Lolait SJ, Bradley DJ, O'Carroll AM, Brownstein MJ, Young WS. 1992. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain. Endocrinology 13:533-535.
53. Ostrowski NL, Lolait SJ, Young WS. 1994. Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. Endocrinology 135:1511-1528.
54. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. 3rd ed. San Diego: Academic Press.
55. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD. 1993. Identification of a receptor for γ-melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci U S A 90:8856-8860.
56. Sakurada C, Watanabe C, Sakurada S, Tan-No K, Sakurada T. 1999. Major metabolites of substance P degraded by spinal synaptic membranes antagonize the behavioral response to substance P in rats. J Pharmacol Sci 88:1127-1132.
57. Schauder B, Schomburg L, Kohrle J, Bauer K. 1994. Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone. Proc Natl Acad Sci U S A 91:9534-9538.
58. Schneider JS, Giardiniere M, Morain P. 2002. Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys. Neuropsychopharmacology 26:176-182.
59. Schulz I, Gerhartz B, Neubauer A, Holloschi A, Heiser U, Hafner M, Demuth HU. 2002. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur J Biochem 269:5813-5820.
60. Shinoda M, Okamiya K, Toide K. 1995. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on thyrotropin-releasing hormone-like immunoreactivity in the cerebral cortex and hippocampus of aged rats. Jpn J Pharmacol 69:273-276.
61. Shinoda M, Toide K, Ohsawa I, Kohsaka S. 1997. Specific inhibitor for prolyl endopeptidase suppresses the generation of amyloid beta protein in NG108-15 cells. Biochem Biophys Res Commun 235:641-645.
62. Taylor WL, Dixon JE. 1980. Catabolism of neuropeptides by a brain proline endopeptidase. Biochem Biophys Res Commun 94:9-15.
63. Todd AJ, Puskár Z, Spike RC, Hughes C, Watt C, Forrest L. 2002. Projection neurons in lamina I of rat spinal cord with the neurokinin 1 receptor are selectively innervated by substance P-containing afferents and respond to noxious stimulation. J Neurosci 22:4103-4113.
64. Toide K, Shinoda M, Takase M, Iwata K, Yoshida H. 1993. Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on extracellular acetylcholine and choline levels in the rat frontal cortex and hippocampus. Eur J Pharmacol 233:21-28.
65. Toide K, Iwamoto Y, Fujiwara T, Abe H. 1995a. JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. J Pharmacol Exp Ther 274:1370-1378.
66. Toide K, Okamiya K, Iwamoto Y, Kato T. 1995b. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats. J Neurochem 65:234-240.
67. Toide K, Fujiwara T, Iwamoto Y, Shinoda M, Okamiya K, Kato T. 1996. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 353:355-362.
68. Toide K, Shinoda M, Miyazaki A. 1998. A novel prolyl endopeptidase inhibitor, JTP-4819. Its behavioral and neurochemical properties for the treatment of Alzheimer's disease. Rev Neurosci 9:17-29.
69. Tonon MC, Desrues L, Lamacz M, Chartrel N, Jenks B, Vaudry H. 1993. Multihormonal regulation of pituitary melanotrophs. Ann N Y Acad Sci 680:175-187.
70. Vaccari C, Lolait SJ, Ostrowski NL. 1998. Comparative distribution of vasopressin Vlb and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 139:5015-5033.
71. Vandenbulcke F, Pollard H, Mitchell V, Beauvillain JC. 1993. Radioimmunocytochemical distribution of neutral endopeptidase (enkephalinase E.C.3.4.24.11) at the ultrastructural level in the rat median eminence. J Neuroendocrinol 5:205-212.
72. Vanhoof G, Goossens F, Hendriks L, De Meester I, Hendriks D, Vriend G, Van Broeckhoven C, Scharpe S. 1994. Cloning and sequence analysis of the gene encoding human lymphocyte prolyl endopeptidase. Gene 149:363-366.
73. Vrinten DH, Gispen WH, Groen GJ, Adan RA. 2000. Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats. J Neurosci 20:8131-8137.
74. Walter R, Shlank H, Glass JD, Schwartz IL, Kerenyi TD. 1971. Leucylglycinamide released from oxytocin by human uterine enzyme. Science 173:827-829.
75. Welches WR, Santos RA, Chappell MC, Brosnihan KB, Greene LJ, Ferrario CM. 1991. Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens 9:631-638.
76. Wilcox JN, Pollard H, Moreau J, Schwartz JC, Malfroy B. 1989. Localization of enkephalinase mRNA in rat brain by in situ hybridization: comparison with immunohistochemical localization of the protein. Neuropeptides 14:77-83.
77. Wilk S. 1983. Prolyl endopeptidase. Life Sci 33:2149-2157.
78. Williams RSB, Eames M, Ryves WJ, Viggars J, Harwood AJ. 1999. Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J 18:2734-2745.
79. Williams RSB, Cheng L, Mudge AW, Harwood AJ. 2002. A common mechanism of action for three mood-stabilizing drugs. Nature 417:292-295.
80. Winkler A, Papsdorf G, Odarjuk J, Siems WE, Fickel J, Melzig MF. 1995. Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells. Eur J Pharmacol 291:51-55.
81. Yamakawa N, Soeda S, Shimeno H, Nagamatsu A. 1986. Purification and characterization of proline endopeptidase from rat liver. Chem Pharm Bull (Tokyo) 34:256-263.
82. Yamanaka C, Lebrethon MC, Vandersmissen E, Gerard A, Purnelle G, Lemaitre M, Wilk S, Bourguignon JP. 1999. Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH. Endocrinology 140:4609-4615.
83. Yoshimoto T, Kado K, Matsubara F, Koriyama N, Kaneto H, Tsuru D. 1987. Specific inhibitors for prolyl endopeptidase and their antiamnesic effect. J Pharmacobiodyn 10:730-735.
84. Yoshimoto T, Oyama H, Koriyama N, Tsuru D. 1988. Prolyl endopeptidase from bovine testis: purification, characterization and comparison with the enzymes from other tissues. Chem Pharm Bull (Tokyo) 36:1456-1462.